Phillipp Gilmore
Phillipp Gilmore

Phillipp Gilmore

      |      

Subscribers

   About

Research has shown that compounds like MDL-18,962 can significantly reduce aromatization, with potential applications in treating estrogen-dependent conditions such as breast cancer. Research has demonstrated that aromatization plays a role in regulating luteinizing hormone (LH) and follicle-stimulating hormone (FSH) secretion. Studies have shown that muscle accounts for 25-30% and adipose tissue for 10-15% of total extragonadal aromatization. While the testes and ovaries are significant sites of aromatization, the process occurs in various other tissues as well. Studies have demonstrated that the aromatization process involves multiple steps, including hydroxylation at the C-19 position of the androgen molecule. Research has shown that aromatization is an early phenomenon in phylogenesis and ontogenesis, occurring in most tissues.
Conflicting results have been obtained concerning the importance of testosterone in maintaining cardiovascular health. In people who have undergone testosterone deprivation therapy, testosterone increases beyond the castrate level have been shown to increase the rate of spread of an existing prostate cancer. It has been theorized that brain masculinization is occurring since no significant changes have been identified in other parts of the body. Among women with congenital adrenal hyperplasia, a male-typical play in childhood correlated with reduced satisfaction with the female gender and reduced heterosexual interest in adulthood.
This belies the fact that the two major hormone classes responsible for these differences, androgens and estrogens, differ only subtly in their chemical backbones. Locally formed estrogen acts to alter synaptic activity, stimulate neuronal connectivity, and enhance cell survival. These exciting new observations hold the promise that someday pharmacologic regulation of brain aromatase could offer therapeutic opportunities for the treatment neurologic disorders and cerebrovascular disease. Classically, aromatase has been implicated in the control of reproductive status, sexual development, neuroendocrine function, and sexual behavior. It has been exhaustively demonstrated that exogenous estradiol reduces ischemic brain injury even in complex animal models with co-morbidities such as hypertension, genetic predisposition to stroke 117, diabetes136, 137 and in aging 138. In addition, there are significant sex differences in how the aromatase is engaged after OGD in male vs. female astrocytes. Early reports confirmed that mechanical trauma or an excitotoxic challenge by intra-cerebral kainic or domoic acid injection leads to increased local aromatase expression and activity 29, 127, 128.
Your diet plays a vital role in testosterone production and aromatization control. One of the most effective strategies for managing aromatization is to reduce excess body fat. Estrogen also plays a protective role in cholesterol management and vascular health by improving HDL levels and decreasing LDL cholesterol. A well-balanced testosterone-to-estrogen ratio is essential for both men and women striving toward fitness goals. A holistic approach to hormone regulation—including lifestyle modification, nutrition, and stress management—can help mitigate these effects. In women, especially during perimenopause and menopause, aromatization can influence estrogen dominance, impacting mood, libido, and bone density (Vermeulen, 2001). This reaction involves the removal of the A-ring from the androgen molecule and the introduction of an aromatic ring, which is where the process gets its name—"aromatization."
We speculated that the female brain is strongly dependent on estradiol production in the ischemic penumbra for favorable outcomes. In addition to aromatase induction in the zone-of-injury, local increases in androgen receptor and estrogen receptor α expression have also been documented 130. These observations set the stage for investigations into how changes in aromatase expression and endogenous estradiol production alter the environment for evolving brain damage.

Gender: Female